Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.
暂无分享,去创建一个
E. Keystone | M. Freedman | D. Malkin | H. Ganjavi | A. Narendran | A. Connor | Natalie Morson | J. Barlow
[1] C. Portwine,et al. Absence of Germline and Somatic p53 Alterations in Children with Sporadic Brain Tumors , 2001, Journal of Neuro-Oncology.
[2] Shin-Seok Lee,et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. , 2002, Arthritis and rheumatism.
[3] S. Rafii,et al. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. , 2002, Blood.
[4] J. Chipman,et al. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. , 2002, Carcinogenesis.
[5] M. Tomonaga,et al. Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] E. Freireich,et al. Angiogenesis and leukemia. , 2001, Leukemia research.
[7] E. Pásaro,et al. Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. , 2001, Mutagenesis.
[8] T. Grogan,et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. , 2001, Blood.
[9] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[10] O. Bruserud,et al. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts. , 2001, Journal of hematotherapy & stem cell research.
[11] A. Wellmann,et al. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. , 2001, Journal of molecular medicine.
[12] L. Gibson,et al. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. , 2000, Blood.
[13] T. Lebien,et al. Fates of human B-cell precursors. , 2000, Blood.
[14] E. Appella,et al. Signaling to p53: breaking the posttranslational modification code. , 2000, Pathologie-biologie.
[15] L. Foroni,et al. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia , 1999, British Journal of Cancer.
[16] T. Grogan,et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. , 1999, Cancer research.
[17] M. Kobayashi,et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. , 1998, Cancer research.
[18] T. Lebien,et al. Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. , 1998, Blood.
[19] T. Lebien,et al. Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. , 1997, Blood.
[20] S. Sallan,et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. , 1997, The American journal of pathology.
[21] J. Shuster,et al. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. , 1996, Blood.
[22] F. Behm,et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. , 1996, The Journal of clinical investigation.
[23] A. Howell,et al. Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma , 1994, International journal of cancer.
[24] W. Kolch,et al. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.
[25] K. Dameron,et al. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. , 1994, Cold Spring Harbor symposia on quantitative biology.
[26] C. Bartram,et al. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. , 1993, Blood.
[27] F. Behm,et al. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.
[28] J. D. Funkhouser,et al. Cancer susceptibility in ataxia-telangiectasia. , 1992, Leukemia.
[29] M. Minden,et al. Mutation of the p53 gene in human acute myelogenous leukemia. , 1991, Blood.
[30] B. Vogelstein,et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.